Search results
This publication of the SHMI relates to discharges in the reporting period February 2018 to January 2019.
The indicators aim to provide clear, comparative information for Clinical Commissioning Groups (CCGs) and Health and Wellbeing Boards (HWBs) about the quality of health services commissioned by CCGs and, as far as possible, the associated health outcomes.
The percentage of cases of lung cancer for which a valid stage at the time of decision to treat is recorded.
The percentage of new cases of cancer which were diagnosed at stage 1 or 2 for the specific cancer sites, morphologies and behaviour: invasive malignancies of breast, prostate, colorectal, lung, bladder, kidney, ovary, uterus, non-Hodgkin lymphoma and invasive melanomas of skin.
The percentage of new cases of cancer for which a valid stage is recorded at the time of diagnosis.
One-year net survival for adults diagnosed with cancer (aged 15 - 99 years), 95% confidence intervals.